Expression of p21 (WAF1/CIP1) protein in clinical thyroid tissues
1996

p21 Protein Expression in Thyroid Carcinoma

Sample size: 93 publication Evidence: moderate

Author Information

Author(s): Y Ito, T Kobayashi, T Takeda, Y Komoike, E Wakasugi, Y Tamaki, M Tsujimoto, N Matsuura, M Mondeni

Primary Institution: Osaka University Medical School

Hypothesis

Does p21 expression in thyroid carcinoma correlate with the characteristics of the carcinoma?

Conclusion

p21 expression is only marginally related to the characteristics of thyroid carcinoma and plays an adjuvant role in regulating its progression.

Supporting Evidence

  • 30.1% of the carcinomas examined were positive for p21.
  • 80% of undifferentiated carcinomas showed co-expression of p21 and p53.
  • p21 expression did not correlate with clinical parameters or patient prognosis.

Takeaway

This study looked at a protein called p21 in thyroid cancer tissues. It found that p21 is not very helpful in understanding how aggressive the cancer is.

Methodology

Immunohistochemistry and Western blotting were used to analyze p21 expression in thyroid tissues from patients undergoing thyroidectomy.

Limitations

The follow-up period was not long enough to obtain meaningful results regarding patient prognosis.

Participant Demographics

Patients undergoing thyroidectomy for thyroid carcinoma and benign tumors, including 93 carcinoma patients and 25 with benign tumors.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication